Links

FIELD: medicine. SUBSTANCE: invention relates to 2-(5-nitronylfuran-2-yl)-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one (2a-z). EFFECT: obtaining novel compounds which exhibit an antiglycating and inhibitory effect on α-glucosidase activity, which can be used in medicine for treating and preventing the consequences of diabetes mellitus.
Translated title of the contribution2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF
Original languageRussian
Patent number2716715
IPCC07D 487/04,A61K 31/519,A61P 9/10,A61P 9/04,A61P 3/10
Filing date30/07/2018
Publication statusPublished - 16 Mar 2020

ID: 12569197